SLC2A1 and colorectal cancer: In addition, GLUT-1 overexpression was also found to be associated with cancer progression and poor survival outcomes in different types of cancer, including bone and soft-tissue sarcomas [26], colorectal cancer [27], breast cancer [28], and lung cancer [29].